These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

304 related items for PubMed ID: 16707886

  • 1. A comparison of the efficacy, relapse rate and side effects among three modalities of systemic corticosteroid therapy for alopecia areata.
    Kurosawa M, Nakagawa S, Mizuashi M, Sasaki Y, Kawamura M, Saito M, Aiba S.
    Dermatology; 2006; 212(4):361-5. PubMed ID: 16707886
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Combined oral pulse and topical corticosteroid therapy for severe alopecia areata in children: a long-term follow-up study.
    Lalosevic J, Gajic-Veljic M, Bonaci-Nikolic B, Nikolic M.
    Dermatol Ther; 2015; 28(5):309-17. PubMed ID: 26179196
    [Abstract] [Full Text] [Related]

  • 6. Pulse corticosteroid therapy for alopecia areata: study of 139 patients.
    Nakajima T, Inui S, Itami S.
    Dermatology; 2007; 215(4):320-4. PubMed ID: 17911990
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Clobetasol propionate 0.05% under occlusion in the treatment of alopecia totalis/universalis.
    Tosti A, Piraccini BM, Pazzaglia M, Vincenzi C.
    J Am Acad Dermatol; 2003 Jul; 49(1):96-8. PubMed ID: 12833016
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Intralesional triamcinolone acetonide in alopecia areata amongst 62 Saudi Arabs.
    Kubeyinje EP.
    East Afr Med J; 1994 Oct; 71(10):674-5. PubMed ID: 7821250
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Efficacy and safety of oral mega pulse methylprednisolone for severe therapy resistant Alopecia areata.
    Bin Saif GA, Al-Khawajah MM, Al-Otaibi HM, Al-Roujayee AS, Alzolibani AA, Kalantan HA, Al-Sheikh OA, Arafah MM.
    Saudi Med J; 2012 Mar; 33(3):284-91. PubMed ID: 22426909
    [Abstract] [Full Text] [Related]

  • 16. Latanoprost in the treatment of eyelash alopecia in alopecia areata universalis.
    Coronel-Pérez IM, Rodríguez-Rey EM, Camacho-Martínez FM.
    J Eur Acad Dermatol Venereol; 2010 Apr; 24(4):481-5. PubMed ID: 20028444
    [Abstract] [Full Text] [Related]

  • 17. Alopecia areata totalis/universalis and systemic corticosteroids.
    Michalowski R.
    Int J Dermatol; 1999 Dec; 38(12):947. PubMed ID: 10671096
    [No Abstract] [Full Text] [Related]

  • 18. Alopecia areata: topical immunotherapy treatment with diphencyprone.
    Avgerinou G, Gregoriou S, Rigopoulos D, Stratigos A, Kalogeromitros D, Katsambas A.
    J Eur Acad Dermatol Venereol; 2008 Mar; 22(3):320-3. PubMed ID: 18005118
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.